The company's increased debt, decreased revenue, and negativ...

Moomoo AI Oct 24, 2023 02:44

The company's increased debt, decreased revenue, and negative EBIT and free cash flow are concerning factors. The balance sheet currently appears weak and poses risks to shareholders, necessitating improvements over time.

Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Is Carrying A Fair Bit Of Debt

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

1168 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3434Followers

0Following

8243Visitors